Australia's new asthma management guidelines now recommend anti-inflammatory reliever (AIR) therapy from day one. This combines low-dose corticosteroids with fast-acting bronchodilators, addressing both symptoms and underlying inflammation. The shift moves away from traditional short-acting bronchodilators alone for better asthma control.
With National Asthma Week (1-7 September) approaching, it's crucial to update your asthma action plan. The 2025 Australian asthma guidelines emphasize maintenance-and-reliever therapy (MART) using combination inhalers for both daily treatment and emergency relief, simplifying management for Australia's 2.8 million people with asthma.
These evidence-based changes reduce severe attacks and improve quality of life through consistent anti-inflammatory treatment.
Ready to discuss how these latest asthma treatment guidelines benefit your care? Book your consultation with Raiqa Health today.